Search research articles
Contact Us
Filters
Showing results (21-30 of 36) with videos related to
Page
of 4
Sort By:
Virology Journal
|
May 19, 2025
Effectiveness of azvudine versus nirmatrelvir/ritonavir for hospitalized patients with SARS-CoV-2 infection and pre-existing liver diseases
Guanyue Su, Feng Gao, Mengzhao Yang, et al.
BMJ Open
|
June 27, 2025
Real-world effectiveness and safety of oral azvudine versus Paxlovid in patients with COVID-19 and pre-existing hypertension: a multicentre, retrospective, cohort study in Henan Province, China
Fuwei Wang, Bohan Jia, Guotao Li, et al.
Scientific Reports
|
February 26, 2026
Evaluating the effectiveness and safety of Azvudine for hospitalised patients with COVID-19 and hypertension: a multicenter retrospective cohort study
Yu Chen, Huan Li, Yichen Ma, et al.
Frontiers in Cellular and Infection Microbiology
|
June 11, 2026
Development of a machine learning-based mortality prediction model for patients with mental disorders and COVID-19
Yi Zhang, Haiyu Wang, Mengzhao Yang, et al.
BMC Infectious Diseases
|
February 25, 2025
Real-world effectiveness and safety of oral Azvudine versus Paxlovid for COVID-19 in patients with kidney disease: a multicenter, retrospective, cohort study
Benchen Rao, Daming Wang, Mengzhao Yang, et al.
Frontiers in Sports and Active Living
|
July 15, 2024
Multiplex influences on vigilance and biochemical variables induced by sleep deprivation
Shiqi Liu, Xiaohong Ma, Ying Chen, et al.
Scientific Reports
|
March 31, 2025
Efficacy and safety of azvudine versus nirmatrelvir/ritonavir in cancer patients with COVID-19
Bohan Jia, Junyi Sun, Di Zhu, et al.
The Journal of Biological Chemistry
|
March 10, 2023
Differential regulation of phosphorylation, structure, and stability of circadian clock protein FRQ isoforms
Xianyun Chen, Xiaolan Liu, Xihui Gan, et al.
Acta Pharmaceutica Sinica. B
|
May 15, 2025
A retrospective cohort study of the efficacy and safety of oral azvudine <i>versus</i> nirmatrelvir/ritonavir in elderly hospitalized COVID-19 patients aged over 60 years
Bo Yu, Haiyu Wang, Guangming Li, et al.
Iscience
|
February 25, 2025
Real-world effectiveness of azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19 and pre-existing diabetes
Guanyue Su, Silin Li, Donghua Zhang, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 36) with videos related to
Sort By:
Page
of 4
Virology Journal
|
May 19, 2025
Effectiveness of azvudine versus nirmatrelvir/ritonavir for hospitalized patients with SARS-CoV-2 infection and pre-existing liver diseases
Guanyue Su, Feng Gao, Mengzhao Yang, et al.
BMJ Open
|
June 27, 2025
Real-world effectiveness and safety of oral azvudine versus Paxlovid in patients with COVID-19 and pre-existing hypertension: a multicentre, retrospective, cohort study in Henan Province, China
Fuwei Wang, Bohan Jia, Guotao Li, et al.
Scientific Reports
|
February 26, 2026
Evaluating the effectiveness and safety of Azvudine for hospitalised patients with COVID-19 and hypertension: a multicenter retrospective cohort study
Yu Chen, Huan Li, Yichen Ma, et al.
Frontiers in Cellular and Infection Microbiology
|
June 11, 2026
Development of a machine learning-based mortality prediction model for patients with mental disorders and COVID-19
Yi Zhang, Haiyu Wang, Mengzhao Yang, et al.
BMC Infectious Diseases
|
February 25, 2025
Real-world effectiveness and safety of oral Azvudine versus Paxlovid for COVID-19 in patients with kidney disease: a multicenter, retrospective, cohort study
Benchen Rao, Daming Wang, Mengzhao Yang, et al.
Frontiers in Sports and Active Living
|
July 15, 2024
Multiplex influences on vigilance and biochemical variables induced by sleep deprivation
Shiqi Liu, Xiaohong Ma, Ying Chen, et al.
Scientific Reports
|
March 31, 2025
Efficacy and safety of azvudine versus nirmatrelvir/ritonavir in cancer patients with COVID-19
Bohan Jia, Junyi Sun, Di Zhu, et al.
The Journal of Biological Chemistry
|
March 10, 2023
Differential regulation of phosphorylation, structure, and stability of circadian clock protein FRQ isoforms
Xianyun Chen, Xiaolan Liu, Xihui Gan, et al.
Acta Pharmaceutica Sinica. B
|
May 15, 2025
A retrospective cohort study of the efficacy and safety of oral azvudine <i>versus</i> nirmatrelvir/ritonavir in elderly hospitalized COVID-19 patients aged over 60 years
Bo Yu, Haiyu Wang, Guangming Li, et al.
Iscience
|
February 25, 2025
Real-world effectiveness of azvudine versus nirmatrelvir-ritonavir in hospitalized patients with COVID-19 and pre-existing diabetes
Guanyue Su, Silin Li, Donghua Zhang, et al.
Page
of 4